Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage Parkinson's Disease

Clinical trial NCT07725562 · RECRUITING

Trial details

NCT number: NCT07725562
Sponsor: Zhejiang Vimgreen Pharmaceuticals, Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson Disease (PD)

Start date: 2026-07-17
Primary completion: 2027-10-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.